T cell gene-engineering to enhance GVT and suppress GVHD

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 3, 2011, Pages 421-433

  Ghorashian, Sara ^a   Nicholson, Emma ^a   Stauss, Hans J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

adoptive T cell therapy; gene modified T cells; graft versus host disease; graft versus leukaemia; T cell receptor

Indexed keywords

BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOIMMUNITY; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DONOR LYMPHOCYTE INFUSION; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; LYMPHOCYTE HOMING; MELANOMA; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE RECEPTOR GENE;

EID: 80052977124     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.05.004     Document Type: Review

References (82)

1. G. Mathe, J.L. Amiel, and L. Schwarzenberg Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemic effects Blood 25 1965, Feb 179 196
2. H.J. Kolb, A. Schattenberg, and J.M. Goldman Graft-Versus-Leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 86 5 1995, Sep 2041 2050
3. J.H. Falkenburg, A.R. Wafelman, and P. Joosten Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes Blood 94 4 1999, Aug 1201 1208 (Pubitemid 29380400)
4. S.A. Rosenberg, J.R. Yannelli, and J.C. Yang Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 J Natl Cancer Inst 86 15 1994, Aug 1159 1166 (Pubitemid 24249302)
5. M.E. Dudley, J.C. Yang, and R. Sherry Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol 26 32 2008, Nov 5233 5239
6. M.J. Besser, R. Shapira-Frommer, and A.J. Treves Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients Clin Cancer Res 16 9 2010, May 1 2646 2655
7. M.M. Horowitz, R.P. Gale, and P.M. Sondel Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 3 1990, Feb 555 562 (Pubitemid 20069191)
8. P.L. Weiden, N. Flournoy, and E.D. Thomas Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts N Engl J Med 300 19 1979, May 1068 1073 (Pubitemid 9198740)
9. P.L. Weiden, K.M. Sullivan, and N. Flournoy Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation N Engl J Med 304 25 1981, Jun 1529 1533 (Pubitemid 11065939)
10. J.F. Apperley, F.R. Mauro, and J.M. Goldman Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect Br J Haematol 69 2 1988, Jun 239 245
11. S. Slavin, E. Naparstek, and A. Nagler Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes Exp Hematol 23 14 1995, Dec 1553 1562 (Pubitemid 26034083)
12. M.Y. Mapara, Y.-M. Kim, and S.-P. Wang Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells Blood 100 5 2002, Sep 1903 1909 (Pubitemid 34925172)
13. C.C. Matte, J. Liu, and J. Cormier Donor apcs are required for maximal GVHD but not for GVL Nat Med 10 9 2004 987 992 (Pubitemid 39273741)
14. P. Reddy, Y. Maeda, and C. Liu A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses Nat Med 11 11 2005 1244 1249 (Pubitemid 43093673)
15. L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 5562 2002, Mar 2097 2100 (Pubitemid 34229476)
16. W.D. Shlomchik Graft-versus-host disease Nat Rev Immunol 7 5 2007 340 352 (Pubitemid 46674485)
17. A.M. Dickinson, X.-N. Wang, and L. Sviland In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens Nat Med 8 4 2002, Apr 410 414 (Pubitemid 34407038)
18. J.L. Ferrara, J.E. Levine, and P. Reddy Graft-versus-host disease The Lancet 373 9674 2009 1550 1561
19. R.A. Morgan, M.E. Dudley, and J.R. Wunderlich Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 5796 2006, Oct 126 129 (Pubitemid 44547756)
20. H.D. Menssen, H.J. Renkl, and U. Rodeck Presence of wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias Leukemia 9 6 1995, Jun 1060 1067
21. K. Inoue, H. Ogawa, and Y. Sonoda Aberrant overexpression of the wilms tumor gene (WT1) in human leukemia Blood 89 4 1997, Feb 1405 1412 (Pubitemid 27080005)
22. L. Gao, I. Bellantuono, and A. Elsässer Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1 Blood 95 7 2000, Apr 1 2198 2203 (Pubitemid 30167714)
23. S.-A. Xue, L. Gao, and D. Hart Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells Blood 106 9 2005, Nov 3062 3067 (Pubitemid 41565901)
24. M.H.M. Heemskerk, M. Hoogeboom, and R. Hagedoorn Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer J Exp Med 199 7 2004, Apr 885 894 (Pubitemid 38481080)
25. M. Griffioen, H.M.E.V. Egmond, and H. Barnby-Porritt Genetic engineering of virus-specific T cells with t-cell receptors recognizing minor histocompatibility antigens for clinical application Haematologica 93 10 2008, Oct 1535 1543
26. T. Stanislawski, R.H. Voss, and C. Lotz Circumventing tolerance to a human mdm2-derived tumor antigen by TCR gene transfer Nat Immunol 2 10 2001, Oct 962 970 (Pubitemid 32976170)
27. J. Kuball, F.W. Schmitz, and R.-H. Voss Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53a2.1-Specific TCR Immunity 22 1 2005, Jan 117 129 (Pubitemid 40143456)
28. E. Sadovnikova, and H.J. Stauss Peptide-Specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy Proc Natl Acad Sci USA 93 23 1996, Nov 13114 13118 (Pubitemid 26382778)
29. E. Sadovnikova, L.A. Jopling, and K.S. Soo Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules Eur J Immunol 28 1 1998, Jan 193 200 (Pubitemid 28048290)
30. N. Labrecque, L.S. Whitfield, and R. Obst How much TCR does a T cell need? Immunity 15 1 2001, Jul 71 82 (Pubitemid 32728321)
31. M.A. de Witte, A. Jorritsma, and A. Kaiser Requirements for effective antitumor responses of TCR transduced T cells J Immunol 181 7 2008, Oct 5128 5136
32. H. Mizuguchi, Z. Xu, and A. Ishii-Watabe Ires-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector Mol Ther 1 4 2000, Apr 376 382
33. M.L. Donnelly, L.E. Hughes, and G. Luke The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2a-like' sequences J Gen Virol 82 Pt 5 2001, May 1027 1041 (Pubitemid 32454603)
34. A.L. Szymczak, C.J. Workman, and Y. Wang Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector Nat Biotechnol 22 5 2004, May 589 594 (Pubitemid 38585911)
35. M. Leisegang, B. Engels, and P. Meyerhuber Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette J Mol Med 86 5 2008, May 573 583
36. S. Thomas, S.-A. Xue, and M. Cesco-Gaspere Targeting the wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells J Immunol 179 9 2007, Nov 5803 5810
37. J. Kuball, M.L. Dossett, and M. Wolfl Facilitating matched pairing and expression of TCR chains introduced into human T cells Blood 109 6 2007, Mar 2331 2338 (Pubitemid 46425872)
38. C.J. Cohen, Y.F. Li, and M. El-Gamil Enhanced antitumor activity of T cells engineered to express t-cell receptors with a second disulfide bond Cancer Res 67 8 2007, Apr 3898 3903 (Pubitemid 46762178)
39. M.A. Daniels, K.A. Hogquist, and S.C. Jameson Sweet 'n' sour: the impact of differential glycosylation on T cell responses Nat Immunol 3 10 2002, Oct 903 910 (Pubitemid 35154002)
40. M.H.M. Heemskerk, R.S. Hagedoorn, and M.A.W.G.V.D. Hoorn Efficiency of t-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex Blood 109 1 2007, Jan 235 243 (Pubitemid 46053064)
41. D.P. Hart, S.-A. Xue, and S. Thomas Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells Gene Ther 15 8 2008, Apr 625 631
42. C.A. Klebanoff, L. Gattinoni, and P. Torabi-Parizi Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells Proc Natl Acad Sci USA 102 27 2005, Jul 9571 9576 (Pubitemid 40981722)
43. C. Berger, M.C. Jensen, and P.M. Lansdorp Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates J Clin Invest 118 1 2008, Jan 294 305
44. C.S. Hinrichs, Z.A. Borman, and L. Cassard Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity Proc Natl Acad Sci USA 106 41 2009, Oct 17469 17474
45. C.S. Hinrichs, R. Spolski, and C.M. Paulos IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy Blood 111 11 2008, Jun 5326 5333
46. M. Perro, J. Tsang, and S.-A. Xue Generation of multi-functional antigen-specific human t-cells by lentiviral TCR gene transfer Gene Ther 17 6 2010, Jun 721 732
47. P.F. Robbins, M.E. Dudley, and J. Wunderlich Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy J Immunol 173 12 2004, Dec 7125 7130 (Pubitemid 39628146)
48. M.E. Dudley, J.R. Wunderlich, and J.C. Yang Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 10 2005, Apr 2346 2357 (Pubitemid 46218728)
49. L. Gattinoni, S.E. Finkelstein, and C.A. Klebanoff Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells J Exp Med 202 7 2005, Oct 907 912 (Pubitemid 41396891)
50. M.P. Colombo, and S. Piconese Regulatory-T-Cell inhibition versus depletion: the right choice in cancer immunotherapy Nat Rev Cancer 7 11 2007, Nov 880 887 (Pubitemid 350006256)
51. M.E. Dudley, J. Wunderlich, and M.I. Nishimura Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma J Immunother 24 4 2001, Jan 363 373 (Pubitemid 32825868)
52. M.E. Dudley, J.R. Wunderlich, and J.C. Yang A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma J Immunother 25 3 2002, Jan 243 251 (Pubitemid 34533314)
53. S.E. Hamilton, M.C. Wolkers, and S.P. Schoenberger The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells Nat Immunol 7 5 2006, May 475 481
54. J.C. Sun, and M.J. Bevan Defective CD8 T cell memory following acute infection without CD4 T cell help Science 300 5617 2003, Apr 339 342 (Pubitemid 36433727)
55. E.M. Janssen, E.E. Lemmens, and T. Wolfe CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes Nature 421 6925 2003, Feb 852 856 (Pubitemid 36254145)
56. D.J. Shedlock, and H. Shen Requirement for CD4 T cell help in generating functional CD8 T cell memory Science 300 5617 2003, Apr 337 339 (Pubitemid 36433726)
57. S.P. Schoenberger, R.E. Toes, and E.I.V.D. Voort T-Cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 393 6684 1998, Jun 480 483
58. A. Corthay, D.K. Skovseth, and K.U. Lundin Primary antitumor immune response mediated by CD4+ T cells Immunity 22 3 2005, Mar 371 383 (Pubitemid 40387478)
59. E.C. Morris, A. Tsallios, and G.M. Bendle A critical role of T cell antigen receptor-transduced MHC class i-restricted helper T cells in tumor protection Proc Natl Acad Sci USA 102 22 2005, May 7934 7939 (Pubitemid 40781041)
60. P. Tiberghien, C.W. Reynolds, and J. Keller Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor t-cell depletion after bone marrow transplantation? Blood 84 4 1994 1333 1341
61. G. Gallot, M.M. Hallet, and J. Gaschet Human hla-specific t-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host- graft-versus-leukemia reaction? Blood 88 3 1996 1098 1103 (Pubitemid 26333337)
62. N.C. Munshi, R. Govindarajan, and R. Drake Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir Blood 89 4 1997 1334 1340 (Pubitemid 27079997)
63. K. Huhlcke, F.A. Ayuk, and Z. Li Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation Bone Marrow Transplant 25 Suppl. 2 2000, May S96 S98
64. S.M. Kornblau, P.G. Aycox, and C. Stephens Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes Exp Hematol 35 5 2007 842 853 (Pubitemid 46601756)
65. C. Bonini, G. Ferrari, and S. Verzeletti HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 276 5319 1997, Jun 1719 1724 (Pubitemid 27421983)
66. F. Ciceri, C. Bonini, and M.T.L. Stanghellini Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study Lancet Oncol 10 5 2009, May 489 500
67. C. Traversari, S. Marktel, and Z. Magnani The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of tk-transduced donor lymphocytes in HSCT for hematologic malignancies Blood 109 11 2007 4708 4715 (Pubitemid 46827762)
68. M. Introna, A.M. Barbui, and F. Bambacioni Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-cd20 antibodies Hum Gene Ther 11 4 2000, Mar 611 620 (Pubitemid 30134304)
69. K.C. Straathof, M.A. Pul, and P. Yotnda An inducible caspase 9 safety switch for t-cell therapy Blood 105 11 2005, Jun 4247 4254 (Pubitemid 40720769)
70. E. Kieback, J. Charo, and D. Sommermeyer A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer Proc Natl Acad Sci U S A 105 2 2008 623 628 (Pubitemid 351171758)
71. B.E. Anderson, J. McNiff, and J. Yan Memory CD4+ T cells do not induce graft-versus-host disease J Clin Invest 112 1 2003, Jul 101 108 (Pubitemid 38056381)
72. P. Hoffmann, J. Ermann, and M. Edinger Donor-Type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 3 2002, Aug 389 399 (Pubitemid 34875667)
73. M. Edinger, P. Hoffmann, and J. Ermann CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 9 2003, Sep 1144 1150 (Pubitemid 37173698)
74. M.H. Albert, Y. Liu, and C. Anasetti Antigen-Dependent suppression of alloresponses by foxp3-induced regulatory T cells in transplantation Eur J Immunol 35 9 2005 2598 2607 (Pubitemid 41404043)
75. G.P. Wright, C.A. Notley, and S.-A. Xue Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis Proc Natl Acad Sci USA 106 45 2009, Nov 19078 19083
76. B.R. Blazar, P.A. Taylor, and A. Panoskaltsis-Mortari Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells J Immunol 162 11 1999 6368 6377 (Pubitemid 29309356)
77. J.M. Coghill, M.J. Carlson, and A. Panoskaltsis-Mortari Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting cc-chemokine receptor 7 on donor T cells Blood 115 23 2010 4914 4922
78. M. Cavazzana-Calvo, S. Hacein-Bey, and G.S. de Basile Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 5466 2000, Apr 669 672 (Pubitemid 30241569)
79. H.B. Gaspar, K.L. Parsley, and S. Howe Gene therapy of x-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector Lancet 364 9452 2004, Jan 2181 2187 (Pubitemid 40018447)
80. M.G. Ott, M. Schmidt, and K. Schwarzwaelder Correction of x-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 Nat Med 12 4 2006, Apr 401 409
81. G.M. Bendle, C. Linnemann, and A.I. Hooijkaas Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy Nat Med 16 5 2010, Apr 565 570 1p following 570
82. S. Okamoto, J. Mineno, and H. Ikeda Improved expression and reactivity of transduced tumor-specific tcrs in human lymphocytes by specific silencing of endogenous TCR Cancer Res 69 23 2009, Dec 9003 9011